Aethlon Medical Inc Kiemelkedően
Mi az Aethlon Medical Inc Kiemelkedően?
A Kiemelkedően az Aethlon Medical Inc - 13.937M
Mi a Kiemelkedően meghatározása?
A fennálló részvények egy olyan vállalat vagy pénzügyi eszköz részvényei, amelyeket a befektetők engedélyeztek, bocsátottak ki és vásároltak meg.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Kiemelkedően a Industrials szektor a NASDAQ-on cégekben a Aethlon Medical Inc -hoz képest
Mit csinál Aethlon Medical Inc?
the aethlon medical (nasdaq:aemd) mission is to create innovative devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. our aethlon adapt™ platform provides the technology foundation for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. the aethlon adapt™ product pipeline includes the hemopurifier®, a first-in-class medical device with broad-spectrum capabilities against exosomes that contribute to the progression of cancer and infectious viral pathogens such as hiv and hepatitis c.
kiemelkedően -hoz hasonló cégek Aethlon Medical Inc
- Savencia SA nak Kiemelkedően 13.910M van
- Capital Bancorp Inc nak Kiemelkedően 13.913M van
- Mafatlal Industries nak Kiemelkedően 13.913M van
- Transcontinental nak Kiemelkedően 13.913M van
- Edison Nation nak Kiemelkedően 13.924M van
- Cegedim SA nak Kiemelkedően 13.927M van
- Aethlon Medical Inc nak Kiemelkedően 13.937M van
- BlackRock Health Sciences Trust nak Kiemelkedően 13.944M van
- Zedge Inc nak Kiemelkedően 13.946M van
- Appulse nak Kiemelkedően 13.968M van
- Pantaflix AG nak Kiemelkedően 13.976M van
- Reviva Pharmaceuticals nak Kiemelkedően 13.982M van
- Precious Metals & Mining Trust nak Kiemelkedően 13.983M van